Investigational drug · Phase 2
ABO1105
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Respiratory Syncytial Virus.
Phase 2Last checked: Nov 19, 2026Latest source record: Dec 17, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "ABO1105"
First trial start
2025
Sep 15, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "ABO1105", any sponsor or status.
Conditions studied
As listed on its trial records.
- Respiratory Syncytial Virus
Approved drugs for the same conditions: RSV · Infectious disease and vaccines
Largest trials
Live from ClinicalTrials.gov: studies naming "ABO1105" as an intervention, largest first.
- Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or AbovePivotal-lookingActive, not recruiting
Suzhou Abogen Biosciences Co., Ltd.Industry
NCT07289542 · 420 participants (planned) · Start Sep 15, 2025 · Primary completion Jan 7, 2026
Drug: ABO1105; Placebo · For: Respiratory Syncytial Virus
Sites: Baise City, China
- Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or AboveActive, not recruiting
Suzhou Abogen Biosciences Co., Ltd.Industry
NCT07289503 · 96 participants · Start May 27, 2025 · Primary completion Sep 4, 2025
Drug: ABO1105; Placebo · For: Respiratory Syncytial Virus
Sites: Baise City, China
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Respiratory Syncytial Virus
- RSVpreF VaccinePhase 33 trials
Pfizer · Respiratory Syncytial Virus, Respiratory Syncytial Virus (RSV)
- SCTV02Phase 21 trial
Sinocelltech Ltd. · Respiratory Syncytial Virus
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.